Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-95.27	6.96	147.24
Graham Fair Price	1254.94	3.17	0.23
PEG	-99.86	< 0.005	< 0.005
Price/Book	95.36	-0.30	-6.38
Price/Cash Flow	-100.00	-1.03	0.00
Prices/Earnings	-97.68	< 0.005	0.11
Price/Sales	-97.68	0.06	2.41
Price/FCF	-100.00	-1.03	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.08	0.08
Operating Margin	-114.13	-0.01	< 0.005
ROA	100.00	9.81	4.91
ROE	-15.09	-30.18	-100.00
ROIC	0.03	0.16	473.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.14	-0.97	85.15
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.05	-3.28	-213.84
EPS QOQ	1.11	18.32	1547.45
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	0.08	1.00	1129.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1.69	0.85	-50.00
Days Sales Outstanding (DSO)	4.36	24.35	458.50
Inventory Turnover	53.25	106.50	100.00
Debt/Capitalization	-1.23	-1.96	-59.96
Quick Ratio	0.09	0.43	376.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	-0.01	-0.12	-858.09
Cash	< 0.005	0.03	858.09
Capex	0.00	< 0.005	-100.00
Free Cash Flow	0.00	-0.03	-100.00
Revenue	0.03	0.65	1816.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.60	0.60	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.03	3.94	-60.71
Naive Interpretation	Member

06 - Financial Health · Bad

Rating